These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. Tan CC; Yu JT; Wang HF; Tan MS; Meng XF; Wang C; Jiang T; Zhu XC; Tan L J Alzheimers Dis; 2014; 41(2):615-31. PubMed ID: 24662102 [TBL] [Abstract][Full Text] [Related]
8. Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population. Prasher VP Int J Geriatr Psychiatry; 2004 Jun; 19(6):509-15. PubMed ID: 15211527 [TBL] [Abstract][Full Text] [Related]
9. Cholinesterase inhibitors in the clinical management of Alzheimer's disease: importance of early and persistent treatment. Seltzer B J Int Med Res; 2006; 34(4):339-47. PubMed ID: 16989488 [TBL] [Abstract][Full Text] [Related]
10. [Retrospective comparative analysis of antidementia medication persistence patterns in Spanish Alzheimer's disease patients treated with donepezil, rivastigmine, galantamine and memantine]. Sicras-Mainar A; Vergara J; Leon-Colombo T; Febrer L; Rejas-Gutierrez J Rev Neurol; 2006 Oct 16-31; 43(8):449-53. PubMed ID: 17033976 [TBL] [Abstract][Full Text] [Related]
11. Antidementia drug use among community-dwelling individuals with Alzheimer's disease in Finland: a nationwide register-based study. Taipale H; Tanskanen A; Koponen M; Tolppanen AM; Tiihonen J; Hartikainen S Int Clin Psychopharmacol; 2014 Jul; 29(4):216-23. PubMed ID: 24608822 [TBL] [Abstract][Full Text] [Related]
12. [Medical treatment of Alzheimer's disease]. Johannsen P Ugeskr Laeger; 2006 Oct; 168(40):3424-9. PubMed ID: 17032609 [TBL] [Abstract][Full Text] [Related]
13. Memantine for patients with Alzheimer disease. Finucane TE JAMA; 2004 Apr; 291(14):1695; author reply 1695. PubMed ID: 15082684 [No Abstract] [Full Text] [Related]
14. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease. Grossberg GT; Edwards KR; Zhao Q J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811 [TBL] [Abstract][Full Text] [Related]
16. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine. Rodda J; Morgan S; Walker Z Int Psychogeriatr; 2009 Oct; 21(5):813-24. PubMed ID: 19538824 [TBL] [Abstract][Full Text] [Related]
17. [Mechanisms of action of Alzheimer medications]. Alhainen K Duodecim; 2003; 119(20):1959-66. PubMed ID: 14640001 [No Abstract] [Full Text] [Related]
18. Current treatments of Alzheimer disease: are main caregivers satisfied with the drug treatments received by their patients? Sevilla C; Jiménez Caballero PE; Alfonso V; González-Adalid M Dement Geriatr Cogn Disord; 2009; 28(3):196-205. PubMed ID: 19738386 [TBL] [Abstract][Full Text] [Related]
19. Lower Barthel Index scores predict less prescription of pharmacological therapy in elderly patients with Alzheimer disease. Formiga F; Fort I; Robles MJ; Rodriguez D; Regalado P Dement Geriatr Cogn Disord; 2010; 29(3):198-203. PubMed ID: 20332637 [TBL] [Abstract][Full Text] [Related]
20. Effective pharmacological management of Alzheimer's disease. Atri A Am J Manag Care; 2011 Nov; 17 Suppl 13():S346-55. PubMed ID: 22214392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]